AHA bulletin highlights Baxter’s efforts to increase access, supply of IV solutions
AHA today Oct. 24 a Special Bulletin with updates from Baxter on its efforts to increase access to and supply of IV solutions in response to the effects of Hurricane Helene on its manufacturing facility in North Carolina. Baxter anticipates restarting the highest-throughput IV solutions manufacturing line at the impacted plant within the next week. In addition, the Food and Drug Administration authorized temporary importation for a variety of products from two additional Baxter plants in Thailand and Singapore, bringing the total number of facilities authorized to import products to seven. See AHA’s Special Bulletin for more updates.
Related News Articles
Headline
The Supreme Court Feb. 20 ruled that the International Emergency Economic Powers Act does not authorize the imposition of global tariffs. The court held that…
Headline
The AHA Feb. 18 responded to a request for information from Reps. Neal Dunn, R-Fla., and Lori Trahan, D-Mass., on the potential reauthorization of the Pandemic…
Headline
Two AHA guides offer strategies for hospitals and health systems in preparing for public health emergencies and disasters and managing cybersecurity incidents…
Headline
The Centers for Medicare & Medicaid Services Jan. 26 released an advanced notice of proposed rulemaking seeking comments on potential future policies to…
Headline
Olympus has expanded a voluntary recall of its ViziShot 2 FLEX Needles due to complaints of device components ejecting or attaching during…
Headline
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In…